Einstein Experts

Search Results

You searched for "cardiovascular disease"

6 results found

Michael H. Alderman, M.D.

Michael H. Alderman, M.D.

Distinguished University Professor Emeritus, Epidemiology & Population Health

Distinguished University Professor Emeritus, Medicine (General Internal Medicine)

Atran Foundation Chair in Social Medicine

HypertensionDietary saltCardiovascular disease

A specialist in hypertension, Dr. Alderman is widely recognized for having questioned public health initiatives to lower the recommended level of dietary salt. His research has focused on understanding the wide variety of cardiovascular outcomes among patients with high blood pressure. Dr. Alderman has been featured by The New York Times, the Associated Press and The Wall Street Journal. read more...

 

Joel Zonszein, M.D.

Joel Zonszein, M.D.

Professor, Clinical Medicine (Endocrinology), Einstein

Director, Clinical Diabetes Center, Montefiore Medical Center

Diabetes (clinical)Type 1 diabetesType 2 diabetes

Diabetes preventionCardiovascular disease

Dr. Zonszein is an experienced clinician and researcher who focuses on preventing and treating types 1 and 2 diabetes. He has participated in landmark NIH studies, including the Diabetes Control and Complications Trial and the Diabetes Prevention Program. He has a special interest in understanding cardiovascular disease in people with diabetes and serves as the principal investigator of an ongoing NIH-sponsored study to find the best way to manage coronary artery disease in patients with type 2 diabetes.  read more...

 

Mario J. Garcia, M.D.

Mario J. Garcia, M.D.

Co-Director, Montefiore Einstein Center for Heart and Vascular Care

Chief, Cardiology, Department of Medicine, Einstein and Montefiore Medical Center

Professor, Medicine (Cardiology), Einstein

Pauline A. Levitt Chair in Medicine, Einstein

Heart DiseaseCardiologyCardiac imaging

Cardiovascular disease

Dr. Zonszein is an experienced clinician and researcher who focuses on preventing and treating types 1 and 2 diabetes. He has participated in landmark NIH studies, including the Diabetes Control and Complications Trial and the Diabetes Prevention Program. He has a special interest in understanding cardiovascular disease in people with diabetes and serves as the principal investigator of an ongoing NIH-sponsored study to find the best way to manage coronary artery disease in patients with type 2 diabetes.  read more...

 

Sylvia Wassertheil-Smoller, Ph.D.

Sylvia Wassertheil-Smoller, Ph.D.

Professor, Epidemiology & Population Health

Dorothy and William Manealoff Foundation & Molly Rosen Chair in Social Medicine

Head, Division of Epidemiology, Department of Epidemiology & Population Health

Epidemiology & population healthHypertensionWomen's health

An authority in epidemiology, Dr. Smoller has made important research contributions in several areas including hormone therapy and cardiovascular disease, depression and antidepressant use as risk factors for cardiovascular disease and stroke, and biomarkers and prediction models of stroke risk. She has had a major role in studies that have helped to change medical practice in the U.S., including the NIH’s Women’s Health Initiative, a long-term study of postmenopausal women, for which she is Einstein’s principal investigator. read more...

 

Robert E. Michler, M.D.

Robert E. Michler, M.D.

Professor and Chair, Surgery, Einstein and Montefiore Medical Center

Professor and Chair, Cardiovascular and Thoracic Surgery, Einstein and Montefiore

Co-Director, Montefiore Einstein Center for Heart and Vascular Care

Surgeon-in-Chief, Montefiore

Cardiac surgeryMitral repair surgeryAortic valve surgery Minimally invasive heart surgeryHeart transplantation

Dr. Michler is a heart surgeon who specializes in complex aortic and mitral valve repair surgery. He is an NIH-funded investigator whose interest in repairing the injured heart has led to clinical trials in cardiac stem cell transplantation. Dr. Michler and his teams have advanced minimally invasive cardiothoracic surgery procedures and surgical robotics. This work led to FDA approval for selective cardiac robotic procedures including mitral valve repair and coronary bypass surgery. read more...

 

Jill P. Crandall, M.D.

Jill P. Crandall, M.D.

Professor, Clinical Medicine (Endocrinology), Einstein

Director, Diabetes Clinical Trials Unit, Einstein

Attending Physician, Endocrinology, Montefiore Medical Center

DiabetesType 2 diabetesDiabetes prevention

Clinical TrialsPrediabetesResveratrol

An expert in diabetes prevention, Dr. Crandall is a principal investigator in the NIH-funded Diabetes Prevention Program Outcomes Study, which showed that sustaining weight loss or taking an anti-diabetic drug can stave off type 2 diabetes in people at high risk for the disease. The American Diabetes Association recently funded Dr. Crandall to study whether the wine ingredient resveratrol can prevent diabetes in patients with prediabetes. read more...